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-Introduction 
The immune system consists (in part) of cells and their products that protect the body 
from attack by infectious agents. Without this vital system, the body would soon succumb to one 
or more of these death-causing agents. Fortunately, the immune system eliminates many of these 
infectious agents before there is any sign of infection. One of the most important groups of cells 
in this system are the T lymphocytes, or T cells. A specific subset of T cells called cytotoxic T 
lyniphocytes, or CTLs, are responsible for surveying the cell surfaces for foreign substances. 
Upon recognition of one of these foreign antigens, the T cell becomes activated and kills the cell 
expressing the antigen. Cells express foreign antigens when infected by foreign microorganisms, 
(i.e. pathogens) or when they have turned cancerous. The CTL then, is involved in protecting the 
body from intracellular pathogens and from the development of tumors. 
The purpose of this project is to gain a better understanding of allorecognition by T cells 
through the use of an alloreactive T cell receptor. (In short, allorecognition is the recognition of 
several molecules by a single T cell receptor.) This understanding will also help us to better' 
understand the positive selection of T cells that occurs during fetal thymic development. During 
fetal development, immature T cells in the thymus are stimulated to continue development or die, 
depending upon their ability to recognize class I MIlC molecules contained in the thymus (1). 
Class I MIlC molecules are antigen-presenting molecules that are necessary for immune 
recognition by T cells. The process of positive selection leads to a population of self-MIlC­
restricted T cells that will recognize peptides only in the context of a class I MIlC molecule that 
was present during development. Occasionally, however, a T cell has the ability to recognize one 
or more non-self class I MIlC molecules that are not normally present in the body. This ability to 
3 
-recognize one or more non-selfMHC molecule(s) that somehow resembles the selfMHC 
molecule is called alloreactivity (2). In some cases, the difference between the training (self) 
molecule and the allo-molecule (non-self) is a single amino acid substitution, while in other cases, 
the sequences differ extensively. 
Michelle Tallquist, a graduate student at the Mayo Graduate School in Rochester 
Minnesota, and I worked with the Kbm3 and Ld alleles of the murine class I major 
histocompatibility complex. These alleles differ at virtually every polymorphic amino acid 
position within the antigen binding cleft and along the a. helices of the MHC molecule 
(3,4)(Figure 1). The mechanism by which a single T cell receptor (TCR) is able to recognize two 
or more MHC molecules is not understood. We believe that there is some difference. in the 
orientation of the TCR contact on the MHC/peptide complexes resulting in a change of epitopes 
(i.e. the portion of the complex recognized) and important contact residues. By selectively 
mutating several points in the two MHC molecules, we hope to disrupt recognition by altering an 
important contact residue in one molecule, while not affecting recognition of the other molecule. 
This result would lead to a better understanding of alloreactivity and positive selection. 
Class I MHC Structure 
Class I MHC molecules are transmembrane glycoproteins that occur on the surface of all 
nucleated cells in the body (with the exception of sperm and trophoblast) and play an important 
role in antigen presentation (1). Each molecule contains a cytoplasmic domain, a transmembrane 
domain as an anchor, and three extracellular domains (1 )(Figure 2). Crystallographic evidence 
reveals that the important extracellular domains include two membrane-proximal, 
immunoglobulin-like domains, termed beta-2 microglobulin (~2M) and alpha 3 (a.3), and two 
4 
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Figure 1: 
The Ld and Kbm3 MHC molecules differ at nearly every polymorphic residue within the 
antigen binding cleft (3,4). The darkened circles indicate the positions of these amino acid 
differences within the binding cleft as viewed from above. The numbers indicate the position of 
the amino acids with respect to the N-terminus (i.e.beginning) of the protein chain. The extreme 
differences in residues presumably alters the array of peptides bound by the two molecules 
through alteration of binding pockets as well as stenc interference (6). 
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-Figure 2: 
A: Cartoon-type drawing of class I MHC molecule projecting from the cell membrane. 
The drawing also shows the close association of the Prmicroglobulin molecule which is produced 
by the transcription and translation of a separate gene. 
B: Top view drawing of the antigen binding cleft. The drawing shows the N-terminus of 
the cx.1 subunit leading into the antiparallel P sheet, and the direction of the strands within the 
sheet. 
c: Side view drawing of the protein showing the termini of the protein, as well as the 
direction of each fold. This drawing again shows the Prmicroglobulin in its close proximity to 
the class I MHC molecule. The binding cleft is also clearly portrayed. 
These figures taken from the text book Immunology (1992) by Janis Kuby (1). 
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distal domains, termed alpha I and alpha 2 (al and (2). The latter domains combine to form 
eight antiparallel ~ strands and two long a helices that form the bottom and sides, respectively, of 
a cleft that binds short peptides (2). The function of the class I MHC molecules is to present 
endogenously produced peptides on the cell surface within this peptide binding groove or cleft 
(5). While the aI, a2, and a3 subunits are all encoded by the same set ofgenes and are one 
continuous protein, the ~2M subunit is actually an associated protein encoded by a different gene. 
Association with the ~2M subunit is required for class I MHC expression on the cell surface (I). 
Class I MHC Function 
MHC/peptide complexes are scanned by CD8+ cytotoxic T cells. Upon recognition of a 
foreign peptide in association with a class I MHC molecule, CD8+ T cells lyse the infected cell and 
keep the infection from spreading. This process is especially important in viral diseases and 
cancers because the peptides produced within a viral-infected or transformed cell differ from those 
produced in a normal cell. 
Current dogma holds that there are a number of pockets within the peptide binding cleft 
that determine the array of peptideswhich a particular MHC molecule can bind (6). Side chains 
on the peptide must fit into and interact with these pockets to allow binding of the peptide within 
the binding cleft through hydrogen bonds and van de Waals interactions (6). The pockets differ 
between alleles, changing the peptide binding motif of each class I molecule. 
T cell recognition occurs when a T cell receptor (TCR) makes contact with and binds to 
an MHC/peptide complex forming a tn-molecular complex (Figure 3). The TCR is believed to 
bind to parts of one or both a helices of the MHC molecule, as well as to the exposed side chains 
of the peptide in the binding cleft (7,8). It has been previously shown that mutations that change 
9 
Figure 3: 
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Representation of the trimolecular complex that forms during immune recognition by a T 
cell receptor. The TCR binds to contact residues on the a. helices and the peptide held within the 
binding groove. The formation of this trimolecular complex somehow signals the T cell to 
become activated and lyse the cell. 
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the side chains of the a helices that point up away from the binding cleft have no effect on the 
peptide array bound by the MIlC molecule (9-12). Grandea and Pullen (9,10) have also 
demonstrated that certain mutations along these side chains lead to an alloresponse by cytotoxic T 
lymphocytes (CTLs), while others do not change the responsiveness of the CTLs. This leads to 
our hypothesis that there are certain side chains off the a helices that act as contact residues for 
the TCR during formation of the trimolecular complex, A study of different TCRs with the same 
MIlC/peptide complex has shown that the contact residues are variable between TCRs (11). We 
hope to show that a single TCR can have different contact residues depending on the complex it is 
recognizing. Our hypothesis accounts for the different peptides needed in the clefts of the two 
molecules to elicit the alloreactive T-cell response because it addresses the complex as a whole. 
Methods 
All work was done at the Mayo Graduate School in Rochester, Minnesota. The project 
was accomplished May-August, 1994 and was continued during January, 1995. It was made 
possible by the summer research program of the Mayo Graduate School, and funding for materials 
came out of the grants from Dr. Larry R. Pease's lab. 
Polymerase Chain Reaction (PCR) 
PCR was carried out in a total volume of 100ul containing O.5ug of sample DNA, 
100pmol of each primer oligonucleotide, 10ul of dNTP, 10ul of 10X 15mM Mg2+ PCR reaction 
buffer, O.5ul ofTaq polymerase, and double distilled sterile H20 (ddH20) to volume. Primers 
were prepared on site in the Mayo molecular biology core facility, and were purified using NAP­
10 desalting columns. After purification, they were eluted in ddH20 and their concentration 
determined by optical density in a spectrophotometer. The thermal cycler file was set for a total of 
12 
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25 cycles consisting of a 94°C denaturing step of one minute, a 50°C annealing step of two 
minutes, and a 72°C extension step ofthree minutes. In theory, each cycle will double the number 
of copies ofDNA with 100% accuracy. However, Taq polymerase does not have the ability to 
proofread the strand as it duplicates and is prone to an error frequency of0.25% (13). This 
frequency is significantly higher than that observed by Ho et al. (14) in the development of site­
directed mutagenesis by overlap extension, which they found to be 0.026%. In either case, 
because of the possibility ofmutations, constructs containing PCR products were carefully 
checked for sequence fidelity against the known sequence of the molecules. 
Genomic Ld DNA was contained in the bacterial expression vector plasmid pBR322, and 
this was used as our source ofLd template. Oligonucleotide fragments ranging in length from 24 
to 36 nucleotides were prepared with specific mismatches that would allow annealing during 
PCR, but would introduce point mutations during the amplification. These mutations introduced 
specific restriction sites within the introns before exon 2, between exons 2 and 3, and after exon 3 
(Figure 4). Kbm3 containing the restriction sites had been prepared for previous studies in the lab, 
so it was not necessary to introduce these mutations. 
Splicing by Overlap Extension (SOEing) by PCR 
Another process for the introduction of point mutations, SOEing is often used for 
changing bases in the middle ofa stretch ofbases (Figure 5). In this case, we wanted to change 
an amino acid between our new restriction sites. Four primers were required, one at each end of 
the DNA fragment (in this case, containing restriction sites), and two new ones with 
complimentary sequences containing a substitution at the same location. Because of their 
complimentary sequences, one allowed extension from it in the 5' direction, and the other 
13 
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Structure of the expression vector SA? (3). The darkened boxes represent exons 2 and 3 
Figure 4: 
which code for the 0.1 and 0.2 domains, respectively. It is within these two exons that the 
mutations were made that define each ofthe constructs. 
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Figure 5: 
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Explanation of the ISOEing" procedure for site-directed mutagenesis. Four primers are 
used in a procedure that utilizes peR twice and results in the precise introduction of nucleotide 
point mutations. 
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Primer A
,
5' 3' 
3' 5'Primer C -X7 Double Stranded Templates 
':'X- Primer D5' 3' 
3' 5' 
,
 
Primer B
 
After the first round of PCR, the predominant amplification products 
are as follows: 
C A 
5' 3' 
3' -x 5' 
5' x- 3'
 
3' 5'
 
B D
 
These products are complementary in the region surrounding the 
mutation (X) and can bind to each other during the second round of 
PCR. The tag ends can then be extended by Taq polymerase. 
C A 
- - - - - -X------------­
--------X- ­
B D 
This results in a mutated segment from between points A and B. 
17 
•
 
terminated extension by annealing farther down the opposite strand. In addition, one of the two 
previously mentioned restriction primers allowed extension and the other caused termination. In 
the first step of the SOEing reaction, the S' restriction primer was paired with the 3' mutation 
primer, while the S' mutation primer was paired with the 3' restriction primer. These two 
reactions were run in separate tubes following standard PCR protocol. A procedure known as 
Gene Clean (Bio 101) was then run on each ofthe reaction products. During this procedure, 
Glassmilk bound the long strands ofDNA and held them while excess primers, short strands of 
DNA «SO bases), and other reagents were decanted away. The DNA was then recovered by 
eluting it off of the Glassmilk beads with SsoC water. Gene Clean was also important after 
restriction digests to eliminate the short end fragments clipped off during the digest, and for 
recovering DNA from agarose gels after separations. 
. . Following Gene Clean, the products of the first reactions were mixed and a second round 
ofPCR was run using only the two restriction primers. During the heating stage, the two double 
stranded DNA molecules separated and mixed. Upon cooling at the annealing stage, some of the 
reannealed molecules were annealed only by their short homologous overlap region (inserted 
using the mutation primers). Taq polymerase then extended the two ends using the tails as 
templates. The result was a single DNA molecule that spanned the two restriction sites 
containing a specifically engineered point mutation. The second PCR step was required to obtain 
the full stretch ofDNA desired. This procedure introduced mutations at amino acids 6S, 72, 79, 
138, 149, and lS8 in both the Ld and the Kbm3 DNA (Figure 6). 
18 
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Figure 6: 
Positions of the mutated amino acid residues within the peptide binding groove. The 
darkened circles represent relative positions ofchanges made using the "SOEing" method. The 
changes in nucleotides resulted in conservative changes in the amino acid sequence (see Table 1). 
The changes only alter side chains projecting away from the peptide binding groove and do not 
affect the array of peptides that bind within the groove (8-12). 
19
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Restriction Enzyme Digests 
Most cuts were made using 0.5ug ofDNA, 10% (1ul) of the appropriate buffer, 10 units 
(luI) of the appropriate enzyme, and sterile water to bring the total volume to 10ul. Some digests 
required a greater quantity ofDNA and thus adjustments in the above quantities. Enzymes and 
buffers were purchased from Boehringer Mannheim, and the reactions were run at the 
recommended optimum temperature for each enzyme. 
Gel Electrophoresis 
DNA fragments were separated based on size and charge using 1.5% agarose gels in TBE 
buffer. TAE buffer was used when the DNA was to be recovered later using Gene Clean. A total 
volume of20ul was loaded into each lane of the gel. This volume contained 0.25-0.5ug ofDNA 
and 5ul of ficoll tracking dye in sterile (double deionized) water. A charge of 90 volts for 2 hours 
was usually sufficient for good separation, but the charge and duration varied depending on the 
importance of resolution and on time constraints ofthe day. Ethidium bromide was mixed into 
the gel before congealing to help visualize the DNA under ultraviolet light. 
Transfections 
Transfections into BW 5147 cells (thymoma or immortal thymus cells) were accomplished 
using lipofectamine to create liposomes that could fuse to the cells and release the DNA contained 
in the liposomes to the cell interior. Lipofectamine is a polycationic lipid that forms complexes 
with DNA due to ionic interactions with the negatively charged phosphate groups (15). These 
complexes have a net positive charge, allowing them to associate with and fuse to the charged cell 
membrane (16). Upon fusion of the outer lipid layer to the plasma membrane, DNA is released to 
the interior of the cell. The plasmid pRc/CMV was cotransfected along with each of the 
21 
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constructs as a selective marker. It contained a neomycin resistant gene and allowed selection of 
successfully transfected cells in a media containing lmg/ml G4l8 (synthetic neomycin). 
Presumably, any cell which integrated the pRc/CMV plasmid also integrated the desired construct 
because the selection plasmid was added in limited quantities (lug construct:.5ug selective 
plasmid). The transfections involved 3.0 x 106 cells which were left in contact with the liposomes 
for five hours before new media was added. After a 24 hour recovery period, the media was 
removed and replaced with the selection media containing G4l8. The cells were then split 
periodically to keep them from becoming too dense in the flask, and the media was changed every 
other day to select for the transfected cells. 
An alternative transfection procedure was used for our second cell line, the mouse 
lymphoma cells (L cells) which do not respond well to the above transfection method. Instead, 
we used a calcium phosphate precipitation procedure to introduce the DNA into the cells. In this 
procedure, 2M CaCh was mixed with the DNA constructs that we wanted to transfect along with 
a cotransfectant plasmid called pHSV and left to stand for 20 minutes at room temperatur~ while 
it formed a CaP04-DNA precipitate. The precipitate was then added to L cells that were plated at 
a density of lxl04/cm2. During the 4 hour incubation time, the DNA was endocytosed by the L 
cells which were then washed free of leftover precipitate and given complete media. After a 48 
hour recovery period, the complete media was replaced with HAT selection media. 
Cells can synthesize nucleotides by either the de novo or salvage pathways. HAT 
selection media contains aminopterin which blocks the de novo synthesis of nucleotides, forcing 
the cell to use the salvage pathway. This salvage pathway requires hypoxanthine and thymidine as 
well as two enzymes. While the HAT media contains the hypoxanthine and thymidine, L cells are 
22 
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not capable of utilizing this pathway because of an enzyme deficiency. The transfected cells were 
separated from untransfected cells because the cotransfected plasmid pHSV contained the genes 
for the enzymes needed to utilize the salvage pathway. Cells that endocytosed pHSV also 
presumably endocytosed the plasmid construct. These cells survived in the HAT media and were 
harvested for analysis. 
Cytotoxic T Lymphocyte Assays 
CTL assays involved labeling target cells with SlCr and subjecting them to effector cells. 
Cells were labeled by adding Na2s1 Cr04 and incubated for I hour, during which time the cells 
absorbed the radiolabel. Once internalized, the radiolabel was only released in the event of cell 
death, either by lysis or spontaneous death. Following the labeling, effector cells were added to 
each well and the mixture was incubated for 5 hours. After incubation, the wells of the plate were 
harvested and counted in a gamma counter. Spontaneous (background) release of chromium was 
measured in control wells that did not have effector cells added. Total lysis was determined by 
the addition of a detergent (Triton X-I 00) to a set ofwells also containing only target cells.' 
Specific lysis was then calculated using the formula: 
% specific lysis = (cpm released by CTL - cpm of spontaneous release) x 100 
(cpm released by detergent - cpm of spontaneous release)
 
Where cpm= counts per minute
 
We added an additional step when T2 cells were used because they are peptide-deficient 
and cannot transport MHC molecules with bound peptide to the cell surface. Instead, they have 
empty peptide binding sites on their MHC molecules. Before adding the effector cells, T2 cells 
were incubated for one hour with a known peptide to sensitize them. We used a peptide 
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designated p2Ca on the Ld constructs, and one designated 2CKbm3E on the Kbm3 constructs. Our 
data suggest these peptides sensitize the respective molecules to 2C TCR recognition (Figure 7). 
DNA Sequencing 
After the PCR steps, it was necessary to sequence the mutated segment of each construct 
to make sure the proper mutation was introduced and no new mutations arose. The first step was 
to transform bacteria with the constructs and culture them overnight. After lysing the bacteria, a 
plasmid preparation was done and the plasmids were ready for sequencing. 
Using oligo primers that bind near the region desired, T7 DNA polymerase synthesized a 
new strand ofDNA until the termination bases were added. Different strands began replication at 
different times and rates due to reaction kinetics, and ended up being different lengths when the 
termination base was added. The product was then separated by polyacrylamide gel 
electrophoresis (pAGE) in a fashion similar to the previously mentioned electrophoresis. One of 
the bases added to the strands during synthesis was 3SS labeled adenine. After drying, the gel was 
exposed to X-ray film and bands showed up after developing. It was then possible to read the 
sequence from the gel. This process was tedious and yielded sequences of about 200 bases per 
primer. Because of the efficiency (350-400 bases per primer) some of the sequencing was done in 
the automated sequencer at the Mayo molecular biology core facility. The manual sequencing 
was done to elucidate problems from the automated sequencer such as compressions and 
unknown bases in the sequence. 
Fluorescence Activated Cell Sorting (FACS) 
FACS uses antibodies tagged with fluorescent compounds to sort cells based on the 
presence or absence of fluorescence when struck with laser light. In our sorts, the antibodies 
24 
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•
 
A: Results of the chromium release assay using T2 transport deficient cells and peptide 
p2Ca. The peptide sensitizes T2Ld cells to 2C TCR recognition in a concentration dependent 
manner while showing no such sensitization on T2Kbm3 cells. 
B: Results of the chromium release assay using T2 transport deficient cells and the 
2CKbm3E peptide. This peptide sensitizes T2Kbm3 cells to 2C TCR recognition in a concentration 
dependent manner while showing no such sensitization on T2Ld cells. 
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were specific for the a 3 domain of the MHC class I molecule. We used a primary monoclonal 
antibody (designated 28-14-8), to bind to the a 3 domain. We then used a secondary antibody 
produced in a goat against the Fe region of murine antibodies. This secondary antibody was 
tagged with a compound called FITC that fluoresces in the green spectrum when struck by the 
laser. 
Along with presence or absence of surface molecules, it was also possible to differentiate 
between live and dead cells, as well as cells ofdifferent sizes. These were determined by 
examining the forward and side scatter ofthe light. The larger the cell, the more light passes 
through it to the detector, and the higher its forward scatter. Side scatter is essentially the 
opposite of forward scatter in that the light that does not pass through the cell is deflected and 
picked up by another sensor. Granular cells, collapsed cells, and various noncellular particles 
generally have a high side scatter. 
The last compound we used was propidium iodide (PI), which is absorbed by dead cells 
and fluoresces in the orange spectrum when struck by laser light. Between forWard scatter, side 
scatter, PI, and fluorescence, it was possible to focus on fairly precise populations of cells and 
sort them out of a larger population. 
Materials 
SA7 Expression Vector 
SA7 is a modified pUC 18 expression vector containing a 1.8-kb Xbal fragment from the 
murine H-2Kb gene, and a 2.S-kb BamID fragment from the H-2Ld gene (3)(Figure 4). The Xbal 
fragment, which encodes the a 1 and a2 domains ofthe class I MHC molecule, has been modified 
to introduce restriction sites that flank the domains. This allows excision of either domain 
28 
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independently of the other, which was important in this project. The 2.5-kb BamHI fragment 
encodes the extracellular 0.3 domain, the transmembrane domain, and the cytoplasmic domain of 
the Ld molecule. This was included to allow determination ofexpression levels of the mutant 
molecule on the cell surface using the monoclonal (mAb) 28-14-8. The antibody binds to the 0.3 
domain ofLd. 
In making the constructs for this project, the Sall and HindlII sites flanking the 0.1 domain 
or the HindIII and Xhol sites flanking the 0.2 domain were used to excise the respective domain 
so it could be replaced with the desired mutated domain. In the case of the Ld constructs, when 
one domain was replaced with a mutated domain, the other was replaced by the wild-type Ld 
domain (i.e. both Kb domains were changed to Ld domains). In the case of the Kbm3 constructs, 
the 0.1 domain of5A7 had to be replaced because of the mutations at amino acids 77 and 89 that 
defihed the Kbm3 mutant MHC molecules from the wild-type Kb molecules. The 0.2 domain could 
be left unchanged unless a mutation was desired within the domain, as was the case with the 138, 
149, and 158 mutants. 
Origin of the 2C TCR 
The 2C TCR was positively selected in an H_2b haplotype mouse which had Kb and Db 
alleles of the MHC genes. In theory, it should have only responded to these two alleles during 
antigen recognition (17). However, this did not occur. The 2C TCR was found to be alloreactive 
on both the Kbm3 allele (a mutant ofthe Kb allele) from H_2b mice, and the Ld allele from H_2d 
mice (17). The ability of the TCR to recognize the mutant molecule is not surprising because of 
the large degree ofhomology between the molecules that was discussed earlier. The ability to 
recognize an allele that was not present during selection, however, is quite intriguing. The means 
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by which this TCR accomplishes this dual recognition is not understood and is the focus of this 
study. 
Cells 
The BW cells were purchased from the American Type Culture Collection (Bethesda, 
MD). 2C T cells were originally derived by Dennis Loh (Washington University) and are now 
isolated from 2C transgenic mice that are maintained in the Mayo Clinic animal facility. T2 cells 
were obtained from Peter Crestwell (Yale University). 
Results and Discussion 
Construct Results 
Before we could test the effects of mutations on T cell recognition, it was first necessary 
to introduce the mutations by using the ItSOEinglt procedure mentioned above. At the end of the 
summer we had determined that we had successfully inserted the mutations at amino acid 
positions 72, 79, 138, 149, and 158 ofKbm3 and amino acid positions 72, 149, and 158 ofLd. This 
gave us three pairs ofmutants to transfect into L cells (a lymphoma line), in an effort to show 
differential recognition between Kbm3 and Ld mutants. Unfortunately, the transfections failed 
during my absence between August, 1994 and January, 1995. Upon my return in January, we 
were able to successfully sequence the Kbm3 65 and Ld79 mutants and had four sets of mutants to 
transfect. Because the first attempt at transfection had failed for an unknown reason, we opted 
for an alternative cell line that had worked well in the past. We transfected the constructs with 
mutations at amino acid 72, 79, 149, and 158 into BW5147 cells. The outcome of these 
transfections is not yet known. 
30 
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As for the remaining two Ld mutations at amino acid 65 and 138, there were some 
unforeseen problems. When we sequenced several clones (from different colonies on a streak 
plate) of the 138 mutant, we found they all shared a single mutation. We hypothesized that this 
could have been a point mutation arising in an early cycle ofPCR and, therefore, showed up in a 
large proportion of the colonies. This led us to a second attempt at constructing the mutant. 
Surprisingly, we found the same mutation upon analysis of sequences from the second attempt. 
Closer analysis of the position ofthe mutation showed that it was in a position that our 
manufactured fusmer should have occupied. Although we requested the proper primer sequence, 
it seemed to have an improper base in it. Either it was constructed improperly, or some 
biochemical process had mutated the oligo. We were forced to reorder the oligo from the Mayo' 
molecular biology core facility and start over. Unfortunately, it was too late in the month to begin 
when we received the oligo. 
The Ld65 mutant is a bit more complex problem. When we sequenced the mutants, we 
found that half of the sequence was correct, while the other half (the half of exon 2 that is 5' to 
our fusmer) was completely wrong. When we entered this nonsense sequence into Genebank, 
which is a database ofgene sequences, it matched it to a region of the E. coli genome that codes 
for glutamine synthetase. It seems that the fusmer is homologous to this region of the E. coli 
genome and can efficiently prime its replication during PCR. PCR requires very small amounts of 
template DNA for the primers to bind and there seems to be enough genomic E. coli template 
mixed in with the plasmid template to be recognized and amplified during PCR. Because we need 
to keep the fusmer sequence to introduce the proper mutation, changing primers is not an option. 
The next step is to obtain a cleaner plasmid preparation. Thus far, most of the plasmid 
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preparations were done using a kit from Promega (Madison, WI), which gives good plasmid yield 
and minimal genomic DNA contamination. Unfortunately, this minimal contamination is still too 
much in this case. In the future, the DNA will have to be purified further using a cesium chloride 
gradient and ultracentrifugation, which will separate the plasmid DNA from the genomic DNA. 
Once the separation is complete, the purified plasmid can then be used with the same fusmer in 
the "SOEing" reaction. 
Transfections are Still in Progress 
After extensive testing, Kathy Allen, a technician in the Pease lab, detennined that the 
pHSV cotransfectant plasmid was somehow degraded. This explained why our transfection had 
not survived the selection process at the end of the summer. If the plasmid is degraded, it will not 
be properly integrated into the host cell DNA and will not be expressed. Without the 
cotransfected plasmid, the cells will die upon addition ofHAT media. Because the selection 
process is faster and leads to clonal populations of cells expressing the transfected protein, we 
opted to attempt the L cell transfections again using new pHSV. Preliminary data suggest that 
the 158 mutants of both alleles are proliferating under selection. The beauty ofL cells is that, 
unlike the BW cells, they are an adherent cell line and will settle individually and begin to divide 
mitotically to form small colonies. These colonies can then be isolated much like bacterial 
colonies to give a clonal population. In contrast, BW cells float in the media while dividing and a 
cell sort must then be done to isolate a majority of the expressing cells. These must then be 
sorted again, after a few days ofproliferation, to yield a population in which the majority of cells 
express the protein transfected, but which is not clonal. The L cell procedure is quicker and leads 
to more uniform cultures which is why it was employed in the beginning. 
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Defining the CTL Assays 
Although we were not able to begin the CTL assays on our transfected cells, we were able 
to run some preliminary tests to determine which of our 2C T cell lines to use, while better 
defining the system we will be dealing with. There were several 2C T cell lines available in the lab 
that were characterized and isolated at different times. We found the lines 2C82793 and 2C32494 
to be most useful in terms of killing specificity, recovery time, and optimal usage time (i.e. the 
amount of time needed after stimulation to obtain specific killing). T cell lines must be stimulated 
weekly with spleen extract to provide them with the targets and cytokines needed for their 
continued prolifer~tion. The two lines we used gave optimal killing between four and six days 
after stimulation. Following this period, cells that were not stimulated again were not active 
enough to kill at an acceptable level. Conversely, using the cells before the four days had elapsed 
resulted in a high rate ofnonspecific target cell lysis due to the hyper-activation of the cells. 
Other cell lines in the lab required greater periods of time after stimulation before they could be 
used in an assay, and were deemed unacceptable due to the short time frame of this project 
Determination ofPeptides Used 
Along with determining the T cell lines to employ, we were also able to support data 
showing that the 2C TCR recognizes the octapeptide p2Ca in the context of the Ld class I MIlC 
molecule (18). T2 cells have been previously transfected in our lab with both the Kbm3 and the Ld 
MIlC molecules. These are peptide transport deficient cells that express "empty" class I 
molecules on their surface. By adding exogenous p2Ca into the empty binding cleft, we were able 
to show a high degree of specific lysis of the T2Ld cells while observing a low killing rate of the 
T2Kbm3 cells (Figure 7A). As a control, we also assayed T2 cells without the addition of 
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exogenous peptide and, as expected, observed a low specific lysis. We have also shown that the 
proposed Kbm3 peptide 2CKbm3E is in fact involved in the alloresponse by the 2C TCR. Michelle's 
thesis work has led her to isolate a potential p2Ca counterpart, 2CKbm3E, which has produced 
similar results with T2Kbm3 cells as p2Ca has produced with T2Kd (19)(Figure 7B). These data 
show that the two MIlC molecules are not only very different in their amino acid sequence, but 
also in the peptide they express (Table 1). This is interesting in terms of defining the different 
types ofalloresponses observed. 
Mechanisms of Allorecognition Studied 
Allorecognition often involves the recognition of highly different MIlC/peptide complexes 
by the same TCR. However, this is not the only type ofalloresponse characterized. It has been 
shown that alloresponses occur in situations where a single amino acid change has occurred with 
no affect on the array of peptides bound (9,10). This small change has affected the interaction 
between the 'fCR and the MIlC/peptide complex leading to an alloresponse. It is also apparent 
that conformational changes in the MIlC molecule or the peptide in the binding groove can cause 
an alloresponse (10,20), which occurs when a mutation causes a slight perturbation of the 
complex's shape. There may be several other mechanisms by which alloreactivity occurs, but 
these are the ones that are well kno~. 
The system employed in this study is of interest because it involves two of the previously 
mentioned mechanisms. It is obvious that the Ld allele is quite different from the 2C training 
molecule (Kb). Therefore, it is believed that a different epitope, but one similar in structure to the 
positively selecting epitope, may be recognized to allow for the alloresponse. The recognition of 
a different epitope would require the TCR to encounter the MIlC/peptide complex at a different 
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Table 1. Sequences of oligonucleotide primers and peptides used throughout the project. 
Oligonucleotide Sequence 
Restriction Primers 
5'GCGTCCTCGGGTCGACCACCGGACCC 3' 
5'CCCAAGTCCAAGCTTCGGGAACAG 3' 
5'GGCTAAGCACTCTCGAGGGAGAAGGCT 3' 
5'GGCTGGGCCCTCTCGAGGGAGAAGGCT 3' 
Kbm3 Fusmers 
5'GAGCGGGAGACAGACAAAGCCAAGGGC 3' 
5'AAGGGCAATGAGATGAGTTTCCGAGTG 3' 
5'CGAGTGGACCTGATGACCCTGCTCGGC 3' 
5'ACGGCGGCGGACAAGGCGGCGCTGATC 3' 
5'CACAAGTGGGAGATGGCTGGTGAAGCA 3' 
5'GAGAGACTCAGGACCTACCTGGAGGGC 3' 
Ld Fusmers 
5'GAGCGGATCACGGACATCGCCAAGGGC 3' 
5'AAGGGCCAGGAGATGTGGTTCCGAGTG 3' 
5'CGAGTGAACCTGATGACCCTGCTCGGC 3' 
5'ACGGCGGCGGACAAGGCGGCGCAGATC 3' 
5'CGCAAGTGGGAGATGGCTGGTGCTGCA 3' 
5'GAGTATTACAGGACCTACCTGGAGGGC 3' 
Peptides Used 
p2Ca: Allows recognition ofLd by the 2C TCR. 
LSPFPFDL or Leu-Ser-Pro-Phe-Pro-Phe-Asp-Leu 
2CKbm3E: Allows recognition ofKbm3 by the 2C TCR. 
EQYKFYSL or Glu-Gln-Tyr-Lys-Phe-Tyr-Ser-Leu 
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Position· Structural Change 
Intron 1 SaIl site
 
Intron 2 HindIlI site
 
Intron 3 Xhol site (Kbm3)
 
Intron 3 Xhol site (Ld)
 
Amino Acid 65 
Amino Acid 72 
Amino Acid 79 
Amino Acid 138 
Amino Acid 149 
Amino Acid 158 
Amino Acid 65 
Amino Acid 72 
Amino Acid 79 
Amino Acid 138 
Amino Acid 149 
Amino Acid 158 
Gln~Asp 
Gln~Met 
Arg~Met 
Met~Lys 
Gln~Met 
Ala~Thr 
Gln~Asp 
Gln~Met 
Arg~Met 
Met~Ly~ 
Gln~Met 
Ala~Thr 
•
 
angle or orientation. The training epitope and the alloepitope would then be degenerate 
recognition sites occurring at different points in their respective complexes. Conversely, the Kbm3 
allele is very similar to the parent Kb molecule and it is believed that the positively selecting 
epitope is the same epitope that leads to the alloresponse. A slight increase in affinity by the TCR 
for the MHC molecule would allow allorecognition and CTL activity. This mutant of the Kb 
molecule differs at two amino acids from the parent molecule, only one of which is associated 
with the binding cleft (Figure 8). Substitution at position 77 presumably alters the conformation 
of the molecule and accounts for the increased affinity and alloreactivity by the 2C TCR (3). 
According to research still in progress (Tallquist, personal communication), it is highly probable 
that the Kb and Kbm3 molecules both contain the same peptide recognized by the 2C TCR. This 
evidence further corroborates the idea that it is the same epitope that is recognized in both 
molecules. If this is the case, the allorecognition ofthe Kbm3 molecule occurs due to the high 
degree of siniilarity between the training molecule and the allomolecule, while the Ld alloresponse 
is directed at the extreme difference of the peptide/MHC complex. This illustrates two di~erent 
forms of allorecognition. One form is characterized by an MHC/peptide complex that is distinct 
from self, while the other is defined by a minor structural perturbation that causes a deviation 
from self that results in allorecognition (19). 
Accomplishments of the Project 
Once we obtain results from the CTL assays ofour transfected mutant molecules, we hope 
to support our hypothesis ofdifferential epitope recognition. By showing that the epitope for 
allorecognition differs between the Ld and Kbm3 molecules, we will show, in an indirect manner, 
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Figure 8: 
Location of the two point mutations that characterize the Kbm3 mutant molecule. The 
mutation at amino acid position 77 results in the allorecognition of this molecule by the 2C TCR 
which was trained on the Kb parent molecule (3). 
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that the epitopes are also different between the Ld and Kb molecules. This will follow because of 
the Kbm3 work done by Pullen et. al. (3). 
This project is not of the proper scope to fully address positive selection. However, if our 
hypothesis is correct, we will further support recent studies (19) implying that the same peptide 
that positively selects the 2C TCR during development is responsible for a hierarchy of 
alloresponses in mutant molecules of the Kb allele. This suggests a new strategy for the isolation 
ofmolecules that govern positive selection during fetal development. In this strategy, mutant~ 
would first be characterized, an allorecognition system determined, and the peptide isolated using 
HPLC fractionation. 
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